SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (Q88292103)
Jump to navigation
Jump to search
scientific article published on 09 March 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor |
scientific article published on 09 March 2020 |
Statements
2 references
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (English)
2 references
Christian Drosten
2 references
Markus Hoffmann
2 references
Hannah Kleine-Weber
2 references
Simon Schroeder
2 references
Nadine Krüger
2 references
Tanja Herrler
2 references
Sandra Erichsen
2 references
Georg Herrler
2 references
Nai-Huei Wu
2 references
Andreas Nitsche
2 references
Stefan Pöhlmann
2 references
Tobias S Schiergens
Marcel A Müller
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
2 references
1 reference